Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05415020 · ClinicalTrials.gov registry record · NA

Determining the Utility of a Behavioral Intervention in Chronic Migraine

A NA study of Migraine and Headache, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05415020 is a NA study of Migraine and Headache that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05415020, a NA study of Migraine and Headache, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.

Interventions

  • BEHAVIORAL Lifestyle Behavior Protocol
  • BEHAVIORAL Sham Behavior Protocol

Study Locations (1)

Arizona

  • Mayo Clinic - Phoenix

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-06-29
Est. Completion 2026-08-14
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05415020

The ClinicalTrials.gov registry entry for NCT05415020 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Behavior Protocol is the first listed.

NCT05415020 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05415020 about?

NCT05415020 is a clinical study titled "Determining the Utility of a Behavioral Intervention in Chronic Migraine". This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protoco...

What is the current status of trial NCT05415020?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-29. Estimated completion is 2026-08-14.

What conditions does trial NCT05415020 study?

This clinical trial studies the following conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Lifestyle Factors.

What interventions are being tested in trial NCT05415020?

The interventions under investigation include: Lifestyle Behavior Protocol (BEHAVIORAL), Sham Behavior Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT05415020?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05415020 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.